KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan‐Cancer Analysis
Open Access
- 1 January 2026
- journal article
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e6916290
Abstract
Dysregulation of histone modifications contributes to the development of cancer. The loss of methylation on histone H3 and H4 and the loss of acetylation serve as indicators of tumors. Histone demethylase KDM3B, which contains a JmjC domain, plays an important role in tumorigenesis and development by removing H3K9me1/2 methylation. It also has a significant impact on regulating different types of cancer. KDM3B′s role in prognosis and tumor formation in cancer has not been thoroughly studied. In this study, we analyzed KDM3B expression data from the TCGA database in a pan‐cancer analysis. Our results show that KDM3B is highly expressed in many cancer types and is closely associated with poor prognosis. KDM3B expression is associated with immune checkpoint activities, lymphocyte infiltration, and immune landscape changes, suggesting that KDM3B could be a target for cancer therapy.Keywords
Funding Information
- Natural Science Foundation of Fujian Province (2022J011063)
- Natural Science Foundation of Fujian Province (2022J011032)
- National Natural Science Foundation of China (82000166)
This publication has 57 references indexed in Scilit:
- Transcriptional repression of ANGPT1 by histone H3K9 demethylase KDM3BBMB Reports, 2015
- Protein Complex Interactor Analysis and Differential Activity of KDM3 Subfamily Members Towards H3K9 MethylationPLOS ONE, 2013
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological ImpactMolecular Cell, 2012
- KDM3B Is the H3K9 Demethylase Involved in Transcriptional Activation of lmo2 in LeukemiaMolecular and Cellular Biology, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancerGut, 2012
- A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromesCancer Genetics, 2011
- Determinants of histone H1 mobility and chromatin binding in living cellsNature Structural & Molecular Biology, 2006
- A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31Oncogene, 2001